Trade Summary

6 days ago, Lu Peng, serving as Chief Medical Officer at Pharvaris N.V. (PHVS), sold 29,700 shares at $34.30 per share, for a total transaction value of $1,018,831.98. Following this transaction, Lu Peng now holds 65,631 shares of PHVS.

This sale represents a 31.15% decrease in Lu Peng's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 25, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 29, 2026 at 6:18 PM ET, 4 days after the trade was made.

Pharvaris N.V. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.